Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02382432Phase 2Completed
Phase 2, randomised trial of dexmedetomidine, sponsored by Assiut University. Primary endpoint: Shivering response rate at 10 months. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02382432.